BridgeBio Oncology Therapeutics, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 88-KOther events8.019.01
- Sep 1S-3Shelf registration
- Aug 11424B3Prospectus for an offering
- Aug 1110-QQuarterly report
- Aug 118-KResults of operations2.029.01
- Jun 22424B3Prospectus for an offering
- Jun 228-KOfficer or director change and shareholder vote5.025.07
- May 13424B3Prospectus for an offering
- May 1210-QQuarterly report
- May 128-KResults of operations2.029.01
- May 6424B3Prospectus for an offering
- Apr 29424B3Prospectus for an offering
- Apr 298-KOfficer or director change5.02
- Apr 22424B3Prospectus for an offering
- Apr 228-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Mar 26424B3Prospectus for an offering
- Mar 268-KOfficer or director change5.02
- Mar 6424B3Prospectus for an offering
- Mar 510-KAnnual report
- Mar 58-KResults of operations2.029.01
- Jan 7424B3Prospectus for an offering
- Jan 7424B3Prospectus for an offering
- Jan 78-KOther events8.019.01
- Nov 12, 202510-QQuarterly report
- Nov 12, 20258-KResults of operations2.029.01
- Sep 10, 2025424B3Prospectus for an offering
- Aug 29, 2025S-1Registration of new shares
- Aug 13, 20258-KMaterial agreement and acquisition or sale of assets completed1.012.013.023.034.015.015.025.035.055.067.018.019.01
- Aug 6, 20258-KRegulation FD disclosure7.019.01
- Aug 4, 20258-KShareholder vote5.07
- Aug 1, 202510-QQuarterly report
- Jul 22, 2025424B3Prospectus for an offering
- Jul 11, 20258-KRegulation FD disclosure7.019.01
- Jul 10, 2025424B4Prospectus for an offering
- May 15, 202510-QQuarterly report
- Mar 11, 202510-KAnnual report
- Mar 1, 20258-KMaterial agreement and unregistered sale of shares1.013.029.01
- Feb 28, 20258-KRegulation FD disclosure7.019.01
- Feb 10, 20258-KOfficer or director change5.029.01
- Nov 14, 202410-QQuarterly report